Merkal Rs

689 citations
33 papers · 572 indexed · h-index 14
    • Infectious Diseases and Mycology 3
    • Veterinary medicine and infectious diseases 3
    • Mycobacterium research and diagnosis 25
    • Herpesvirus Infections and Treatments 2
    • Pharmacological Effects of Natural Compounds 2
  • Microbiology top 10%
    • Microbial infections and disease research 5
    • Tuberculosis Research and Epidemiology 6
    • Diagnosis and treatment of tuberculosis 3
Journals
Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (32 papers)

In The Last Decade

Merkal Rs

32 papers receiving 507 citations

Peers

Merkal Rs
Comparison fields: 5 of 50
  • Small Animals 213
  • Epidemiology 524
  • Pharmacology 89
  • Microbiology 59
  • Infectious Diseases 147
Replace Larsen Ab with:
Larsen Ab
A. B. Larsen United States
George Ghobrial United States
J. Thompson United Kingdom
V. SAUNDERS Australia
Karen Rudge United Kingdom
Z. M. Kunze United Kingdom
Virginie Thibault France
Wiebren Santema Netherlands
Teresa G. Martins Portugal
Merkal Rs relative to Larsen Ab Larsen Ab's profile →
Citations per field
00.5×1.5×
Larsen Ab · 1×
Citations per year

Countries citing papers authored by Merkal Rs

Since Specialization
Citations

This map shows the geographic impact of Merkal Rs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merkal Rs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merkal Rs more than expected).

Fields of papers citing papers by Merkal Rs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merkal Rs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merkal Rs. The network helps show where Merkal Rs may publish in the future.

Co-authorship network

The 11 scholars most cited alongside Merkal Rs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Merkal Rs Line = papers co-authored together Merkal Rs links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Intrauterine inoculation of Mycobacterium paratuberculosis into guinea pigs and cattle.
198229
2
Effectiveness of killed virulent cell vaccine against paratuberculosis.
19794
3
In vitro lymphocyte transformation as a herd survey method for bovine paratuberculosis.
197813
4
Lymphocyte transformation: an aid in the diagnosis of paratuberculosis.
197726
5
Subcutaneous exposure of calves to Myobacterium paratuberculosis compared with intravenous and oral exposures.
197713
6
Analysis of the effects of inapparent bovine paratuberculosis.
197523
7
Clofazimine treatment of cows naturally infected with Mycobacterium paratuberculosis.
197313
8
Laboratory diagnosis of bovine paratuberculosis.
197332
9
Certain blood constituent concentrations in cattle with paratuberculosis.
19725
10
Hematologic changes associated with intravenous johnin testing in cattle.
19714
11
Susceptibility of horses to Mycobacterium paratuberculosis.
197129
12
Hypersensitivity and serologic responses in cattle vaccinated with disrupted Mycobacterium paratuberculosis cells and subsequently infected with Mycobacterium bovis.
19697
13
Experimental paratuberculosis in sheep after oral, intratracheal, or intravenous inoculation: histochemical localization of dehydrogenase activities.
19688
14
The effect of management on the incidence of clinical Johne's disease.
19687
15
Comparison of Mycobacterium paratuberculosis and other mycobacteria, using standard cytochemical tests.
19667
16
Improved methods for primary cultivation of Mycobacterium paratuberculosis.
19624
17
A technique for concentrating Mycobacterium paratuberculosis present in intestinal mucosa.
19613
18
Methods of injecting tuberculin in cattle.
19571
19
Survival time of Mycobacterium paratuberculosis.
195656
20
A comparison of regular intradermic johnin and a purified protein derivative of intradermic johnin on artificially and naturally sensitized ruminants.
19552

About Merkal Rs

Merkal Rs is a scholar working on Small Animals, Microbiology, Epidemiology, Infectious Diseases and Pharmacology, having authored 33 papers that have together received 572 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (25 papers), Tuberculosis Research and Epidemiology (6 papers), Microbial infections and disease research (5 papers), Infectious Diseases and Mycology (3 papers), Diagnosis and treatment of tuberculosis (3 papers), Veterinary medicine and infectious diseases (3 papers), Herpesvirus Infections and Treatments (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Small Animals (213 citations), Epidemiology (524 citations), Pharmacology (89 citations), Microbiology (59 citations) and Infectious Diseases (147 citations). Frequent co-authors include Larsen Ab, Thurston, Miller Jm, Buergelt Cd, Duncan, Bryner Jh, Whitlock Rh, Merritt Am, S.A.M. Selway and Richard Jl. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026